PRTN3 and rheumatoid arthritis: In 2019, Alpizar-Rodriguez et al., reported that Pc. was enriched in the gut microbiome of asymptomatic European first-degree relatives of RA patients with immunity against citrullinated peptides, when their stool microbiome was compared to asymptomatic first degree relatives without ACPA (161).